Immune-related adverse events from cabozantinib plus atezolizumab as first-line treatment for advanced kidney cancer
The COSMIC-021 clinical trial investigated a combination of cabozantinib and [...]
Cabozantinib plus atezolizumab for non-clear cell renal cell carcinoma
In this video interview with Dr Monty Pal from the [...]
Treatment selection for metastatic kidney cancer based on gene expression
The discovery of a reliable biomarker for metastatic renal cell [...]
Avelumab plus axitinib combintion approved for untreated advanced kidney cancer in Scotland
The Sottish Medicine Consortium (SMC) have issued a final decision to recommend [...]
Selection of advanced kidney cancer patients for nephrectomhy
In this study, 6,043 patients with metastatic renal cell carcinoma [...]
Quality versus quantity of life with cabozantinib and sunitinib in advanced kidney cancer
Cabozantinib and sunitinib are both drugs that block the development [...]
Most coronavirus-positive cancer patients are asymptomatic
Most studies have shown that many cancer patients are at [...]
ESMO Virtual 2020: Impact of immunotherapy on quality of life
In this video interview, Dr Jeffrey Kirshner from the Haematology-Oncology Associates [...]
Safety and efficacy of TiNivo in patients with metastatic kidney cancer
Tivozanib is a drug that blocks the blood supply to [...]
NHS England to introduce ‘One Stop Shops’ for life-saving checks
In a major report, the NHS proposing to radically overhaul [...]
